PL375437A1 - Synteza gatifloksacyny - Google Patents

Synteza gatifloksacyny

Info

Publication number
PL375437A1
PL375437A1 PL03375437A PL37543703A PL375437A1 PL 375437 A1 PL375437 A1 PL 375437A1 PL 03375437 A PL03375437 A PL 03375437A PL 37543703 A PL37543703 A PL 37543703A PL 375437 A1 PL375437 A1 PL 375437A1
Authority
PL
Poland
Prior art keywords
gatifloxacin
synthesis
Prior art date
Application number
PL03375437A
Other languages
English (en)
Inventor
Valerie Niddam-Hildesheim
Ben-Zion Dolitzky
Gideon Pilarski
Greta Sterimbaum
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of PL375437A1 publication Critical patent/PL375437A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL03375437A 2002-08-14 2003-08-14 Synteza gatifloksacyny PL375437A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40351402P 2002-08-14 2002-08-14
US46120203P 2003-04-07 2003-04-07

Publications (1)

Publication Number Publication Date
PL375437A1 true PL375437A1 (pl) 2005-11-28

Family

ID=32853154

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03375437A PL375437A1 (pl) 2002-08-14 2003-08-14 Synteza gatifloksacyny

Country Status (7)

Country Link
US (3) US7531656B2 (pl)
EP (1) EP1478642A1 (pl)
JP (1) JP2006516152A (pl)
AU (1) AU2003262704A1 (pl)
CA (1) CA2495271A1 (pl)
PL (1) PL375437A1 (pl)
WO (1) WO2004069825A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005534633A (ja) * 2002-05-10 2005-11-17 テバ ファーマシューティカル インダストリーズ リミティド ガチフロキサシンの新規結晶形
US20060258677A1 (en) * 2003-02-15 2006-11-16 Teva Pharmaceutical Industries Ltd. Novel crystalline forms of gatifloxacin and processes for preparation
US20060247255A1 (en) * 2005-05-02 2006-11-02 Patel Satishkumar A Method for preparing a stable gatifloxacin composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO166131C (no) 1985-06-20 1991-06-05 Daiichi Seiyaku Co Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
JPH089597B2 (ja) 1986-01-21 1996-01-31 杏林製薬株式会社 選択毒性に優れた8‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JPS63198664A (ja) 1986-03-31 1988-08-17 Sankyo Co Ltd キノロンカルボン酸誘導体
KR920003605B1 (ko) 1990-03-27 1992-05-04 한국과학기술연구원 피페라지닐 퀴놀론 유도체의 제조방법
DE4019023A1 (de) 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
JPH0778065B2 (ja) 1990-07-06 1995-08-23 杏林製薬株式会社 (6,7―置換―8―アルコキシ―1―シクロプロピル―1,4―ジヒドロ―4―オキソ―3―キノリンカルボン酸―o▲上3▼,o▲上4▼)ビス(アシルオキシ―o)ホウ素化合物及びその塩並びにその製造方法
KR0125115B1 (ko) 1994-03-22 1997-12-05 김은영 (-)피페라진 벤즈옥사진 유도체의 제조방법
JP3449658B2 (ja) * 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた8−アルコキシキノロンカルボン酸水和物並びにその製造方法
US6413969B1 (en) 2000-09-13 2002-07-02 Bristol-Myers Squibb Company Gatifloxacin pentahydrate

Also Published As

Publication number Publication date
JP2006516152A (ja) 2006-06-22
WO2004069825A1 (en) 2004-08-19
US7531656B2 (en) 2009-05-12
CA2495271A1 (en) 2004-08-19
US20070072868A1 (en) 2007-03-29
AU2003262704A1 (en) 2004-08-30
US20050080264A1 (en) 2005-04-14
US20080188658A1 (en) 2008-08-07
EP1478642A1 (en) 2004-11-24

Similar Documents

Publication Publication Date Title
HK1173394A1 (zh) 二酮哌嗪的合成
SI1476162T1 (sl) Nadzirana sinteza ziprasidona
ZA200605348B (en) Solid forms of anti-EGFR-antibodies
AU154703S (en) Set of trocars
AU2003262794A8 (en) Total synthesis of heparin
EP1639121A4 (en) SYNTHESIS OF BETA-L-2-DESOXYNUCLEOSIDES
IL166592A0 (en) Novel crystalline forms of gatifloxacin
GB0321091D0 (en) Synthesis
IL165115A0 (en) Novel crystalline forms of gatifloxacin
AU2003246963A8 (en) Synthesis of cyclohexanone derivatives
GB0204140D0 (en) Production of olefins
PL375437A1 (pl) Synteza gatifloksacyny
AU2003262141A8 (en) Preperation of desloratatine
MXPA02004180A (es) Metodos de sintesis de dl-hidroxi-alquil-fenil amidas.
AU2003298725A8 (en) Preparation of metallotexaphyrins
IL165690A0 (en) Novel crystalline forms of gatifloxacin
EG24122A (en) Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines
AU2003217354A8 (en) Synthesis of sulfamidates
GB0329319D0 (en) Synthesis
EP1486485A4 (en) NEW 5-HYDROXYCARBAMIMIDOYL-2-HYDROXYBENZENESULFONAMIDE DERIVATIVE CRYSTALS
GB2387171B (en) Synthesis of enamines
GB0328318D0 (en) Synthesis of spongosine
TW533849U (en) Improved structure of cover for wet-towel case
IL163778A0 (en) Processes for the synthesis of chloroadenosine andmethylthioadenosine
GB0225106D0 (en) Synthesis of 3 hydroxy-5 -steroids

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)